Global Interventional Neurology Devices Market - 2025 -2033
Interventional Neurology Devices Market Size
The global interventional neurology devices market size reached US$ 2.31 Billion in 2024 from US$ 2.18 Billion in 2023 and is expected to reach US$ 4.11 Billion by 2033, growing at a CAGR of 6.7% during the forecast period 2025-2033.
Interventional Neurology Devices Market Overview
The interventional neurology devices market is evolving rapidly as advances in minimally invasive technology reshape the treatment landscape for stroke and other neurovascular disorders. Rising global incidence of ischemic and hemorrhagic strokes, coupled with the growing prevalence of cerebral aneurysms and arteriovenous malformations, is fueling steady demand for innovative endovascular solutions. Regulatory agencies like the FDA and EMA are supporting innovation through streamlined approvals, leading to notable product launches, including Johnson & Johnson’s CEREGLIDE 71 and EMBOGARD and Penumbra’s RED reperfusion catheters.
North America dominates due to its advanced infrastructure and reimbursement frameworks, and Asia-Pacific is emerging as the fastest-growing region, driven by expanding healthcare investment and awareness campaigns. Despite its promise, the market faces restraints such as high device costs, reimbursement gaps in developing economies, and risks of complications like vessel perforation or device migration. However, ongoing innovation in biocompatible materials, robotics, and AI-assisted imaging presents opportunities for safer, faster, and more precise interventions. Overall, the market is positioned for sustained growth, underpinned by clinical necessity, technological progress, and a global push toward improving outcomes for stroke and neurovascular patients.
Interventional Neurology Devices Market Dynamics
Drivers:
The rising global incidence of stroke and neurovascular disorders is significantly driving the interventional neurology devices market growth
The rising global incidence of stroke and other neurovascular disorders has directly expanded the addressable patient population for endovascular interventions, lifting demand for interventional neurology devices as more patients become eligible for minimally invasive treatment. Manufacturers are responding with targeted product introductions aimed at those expanded indications, for instance, Johnson & Johnson’s CEREGLIDE 71 intermediate/aspiration catheter and EMBOGARD balloon guide were positioned to improve direct aspiration and combined-tech thrombectomy workflows.
According to the Centers for Disease Control and Prevention (CDC), every year, more than 795,000 people in the United States have a stroke. About 610,000 of these are first or new strokes. Additionally, according to the World Health Organization (WHO), more than 3 billion people worldwide were living with a neurological condition. This expanded patient pool also accelerates post-market evidence generation, which in turn feeds regulatory approvals and label expansions that further enlarge the market. Because many new stroke patients present beyond the old treatment windows, catheter and aspiration technology innovations that increase first-pass success are particularly valuable and see faster uptake.
Restraints:
Device-related risks, complications, and safety concerns are hampering the growth of the interventional neurology devices market
Despite strong momentum, the interventional neurology devices market faces significant headwinds from device-related risks, complications, and ongoing safety concerns, which collectively dampen physician confidence and slow broader adoption. While mechanical thrombectomy and flow diversion have revolutionized stroke and aneurysm care, real-world practice still reports complications such as vessel perforation, in-stent thrombosis, coil migration, incomplete clot retrieval, and distal embolization, which can result in serious morbidity or mortality.
Embolic coils and liquid embolics also face scrutiny for potential migration or incomplete occlusion, leading to retreatment and driving up costs for hospitals and payers. Reports of device malfunctions or recalls not only disrupt supply but also heighten liability concerns, pushing hospitals to adopt a more cautious stance toward newer or less proven technologies. Moreover, these risks translate into payer skepticism, with insurers and health systems demanding robust long-term evidence before granting reimbursement for premium devices. As a result, while innovation continues to push the field forward, persistent concerns about device-related complications remain a critical brake on market growth, influencing procurement decisions and physician preferences until confidence is rebuilt through safer designs and stronger clinical evidence.
Interventional Neurology Devices Market, Segment Analysis
The global interventional neurology devices market is segmented based on device type, indication, end-user, and region.
The ischemic stroke segment from the indication is dominating the interventional neurology devices market with a 32.98% share in 2024
The ischemic stroke segment dominates the interventional neurology devices market because mechanical thrombectomy has become the standard of care for large vessel occlusions, driving higher procedural volumes than any other neurovascular indication. Major and emerging market players have responded with continuous product innovation aimed at improving first-pass efficacy, reducing procedure times, and enabling combination techniques.
For instance, in February 2025, Johnson & Johnson MedTech launched the CEREGLIDE 92 Catheter System, a next-generation .092” catheter with the INNERGLIDE 9 delivery aid, indicated for use in facilitating the insertion and guidance of interventional devices in the neurovascular system. CEREGLIDE 92 is a .092' inner diameter catheter system that allows physicians to achieve large distal access and is designed to provide flow reduction in the M1i when inserting devices for the revascularization of patients with acute ischemic stroke.
Additionally, Stryker’s Trevo NXT ProVue Retriever, a widely adopted stent retriever, has been a cornerstone product in acute ischemic stroke. These product launches and platform upgrades reinforce the central role of ischemic stroke treatment in driving overall market revenue. Unlike aneurysm or AVM interventions, ischemic stroke procedures are highly time-sensitive and occur at a much greater frequency, which amplifies device utilization rates.
Interventional Neurology Devices Market, Geographical Analysis
North America is expected to dominate the global interventional neurology devices market with a 42.19% in 2024
North America, especially the United States, remains the dominant region in the interventional neurology devices market, driven by its advanced healthcare infrastructure, strong reimbursement systems, and high prevalence of stroke and neurovascular disorders. Recent product launches underscore the region’s leadership role, with Johnson & Johnson’s Cereglide 92 Catheter System, a new next-generation catheter to be used when treating acute ischemic stroke patients in February 2025.
Similarly, in February 2025, Penumbra launched the ACCESS25 Delivery Microcatheter, a single-lumen medical device designed to aid physicians in accessing the neurovasculature for the delivery of Penumbra’s advanced .020” coil platform. ACCESS25 is compatible with Penumbra’s MIDWAY Intermediate catheters and BENCHMARK/BMX guide catheters and was designed to facilitate ease of trackability and stable support when delivering Penumbra’s unique .020” coils for neurovascular embolization, such as PC400, POD400, and PAC400.
Interventional Neurology Devices Market Competitive Landscape
Top companies in the interventional neurology devices market include Medtronic, Stryker, Johnson & Johnson, Penumbra, Inc., Terumo Corporation, Boston Scientific Corporation, MicroPort Scientific Corporation, and Acandis GmbH, among others.
The global interventional neurology devices market report delivers a detailed analysis with 56 key tables, more than 57 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.
The global interventional neurology devices market size reached US$ 2.31 Billion in 2024 from US$ 2.18 Billion in 2023 and is expected to reach US$ 4.11 Billion by 2033, growing at a CAGR of 6.7% during the forecast period 2025-2033.
Interventional Neurology Devices Market Overview
The interventional neurology devices market is evolving rapidly as advances in minimally invasive technology reshape the treatment landscape for stroke and other neurovascular disorders. Rising global incidence of ischemic and hemorrhagic strokes, coupled with the growing prevalence of cerebral aneurysms and arteriovenous malformations, is fueling steady demand for innovative endovascular solutions. Regulatory agencies like the FDA and EMA are supporting innovation through streamlined approvals, leading to notable product launches, including Johnson & Johnson’s CEREGLIDE 71 and EMBOGARD and Penumbra’s RED reperfusion catheters.
North America dominates due to its advanced infrastructure and reimbursement frameworks, and Asia-Pacific is emerging as the fastest-growing region, driven by expanding healthcare investment and awareness campaigns. Despite its promise, the market faces restraints such as high device costs, reimbursement gaps in developing economies, and risks of complications like vessel perforation or device migration. However, ongoing innovation in biocompatible materials, robotics, and AI-assisted imaging presents opportunities for safer, faster, and more precise interventions. Overall, the market is positioned for sustained growth, underpinned by clinical necessity, technological progress, and a global push toward improving outcomes for stroke and neurovascular patients.
Interventional Neurology Devices Market Dynamics
Drivers:
The rising global incidence of stroke and neurovascular disorders is significantly driving the interventional neurology devices market growth
The rising global incidence of stroke and other neurovascular disorders has directly expanded the addressable patient population for endovascular interventions, lifting demand for interventional neurology devices as more patients become eligible for minimally invasive treatment. Manufacturers are responding with targeted product introductions aimed at those expanded indications, for instance, Johnson & Johnson’s CEREGLIDE 71 intermediate/aspiration catheter and EMBOGARD balloon guide were positioned to improve direct aspiration and combined-tech thrombectomy workflows.
According to the Centers for Disease Control and Prevention (CDC), every year, more than 795,000 people in the United States have a stroke. About 610,000 of these are first or new strokes. Additionally, according to the World Health Organization (WHO), more than 3 billion people worldwide were living with a neurological condition. This expanded patient pool also accelerates post-market evidence generation, which in turn feeds regulatory approvals and label expansions that further enlarge the market. Because many new stroke patients present beyond the old treatment windows, catheter and aspiration technology innovations that increase first-pass success are particularly valuable and see faster uptake.
Restraints:
Device-related risks, complications, and safety concerns are hampering the growth of the interventional neurology devices market
Despite strong momentum, the interventional neurology devices market faces significant headwinds from device-related risks, complications, and ongoing safety concerns, which collectively dampen physician confidence and slow broader adoption. While mechanical thrombectomy and flow diversion have revolutionized stroke and aneurysm care, real-world practice still reports complications such as vessel perforation, in-stent thrombosis, coil migration, incomplete clot retrieval, and distal embolization, which can result in serious morbidity or mortality.
Embolic coils and liquid embolics also face scrutiny for potential migration or incomplete occlusion, leading to retreatment and driving up costs for hospitals and payers. Reports of device malfunctions or recalls not only disrupt supply but also heighten liability concerns, pushing hospitals to adopt a more cautious stance toward newer or less proven technologies. Moreover, these risks translate into payer skepticism, with insurers and health systems demanding robust long-term evidence before granting reimbursement for premium devices. As a result, while innovation continues to push the field forward, persistent concerns about device-related complications remain a critical brake on market growth, influencing procurement decisions and physician preferences until confidence is rebuilt through safer designs and stronger clinical evidence.
Interventional Neurology Devices Market, Segment Analysis
The global interventional neurology devices market is segmented based on device type, indication, end-user, and region.
The ischemic stroke segment from the indication is dominating the interventional neurology devices market with a 32.98% share in 2024
The ischemic stroke segment dominates the interventional neurology devices market because mechanical thrombectomy has become the standard of care for large vessel occlusions, driving higher procedural volumes than any other neurovascular indication. Major and emerging market players have responded with continuous product innovation aimed at improving first-pass efficacy, reducing procedure times, and enabling combination techniques.
For instance, in February 2025, Johnson & Johnson MedTech launched the CEREGLIDE 92 Catheter System, a next-generation .092” catheter with the INNERGLIDE 9 delivery aid, indicated for use in facilitating the insertion and guidance of interventional devices in the neurovascular system. CEREGLIDE 92 is a .092' inner diameter catheter system that allows physicians to achieve large distal access and is designed to provide flow reduction in the M1i when inserting devices for the revascularization of patients with acute ischemic stroke.
Additionally, Stryker’s Trevo NXT ProVue Retriever, a widely adopted stent retriever, has been a cornerstone product in acute ischemic stroke. These product launches and platform upgrades reinforce the central role of ischemic stroke treatment in driving overall market revenue. Unlike aneurysm or AVM interventions, ischemic stroke procedures are highly time-sensitive and occur at a much greater frequency, which amplifies device utilization rates.
Interventional Neurology Devices Market, Geographical Analysis
North America is expected to dominate the global interventional neurology devices market with a 42.19% in 2024
North America, especially the United States, remains the dominant region in the interventional neurology devices market, driven by its advanced healthcare infrastructure, strong reimbursement systems, and high prevalence of stroke and neurovascular disorders. Recent product launches underscore the region’s leadership role, with Johnson & Johnson’s Cereglide 92 Catheter System, a new next-generation catheter to be used when treating acute ischemic stroke patients in February 2025.
Similarly, in February 2025, Penumbra launched the ACCESS25 Delivery Microcatheter, a single-lumen medical device designed to aid physicians in accessing the neurovasculature for the delivery of Penumbra’s advanced .020” coil platform. ACCESS25 is compatible with Penumbra’s MIDWAY Intermediate catheters and BENCHMARK/BMX guide catheters and was designed to facilitate ease of trackability and stable support when delivering Penumbra’s unique .020” coils for neurovascular embolization, such as PC400, POD400, and PAC400.
Interventional Neurology Devices Market Competitive Landscape
Top companies in the interventional neurology devices market include Medtronic, Stryker, Johnson & Johnson, Penumbra, Inc., Terumo Corporation, Boston Scientific Corporation, MicroPort Scientific Corporation, and Acandis GmbH, among others.
The global interventional neurology devices market report delivers a detailed analysis with 56 key tables, more than 57 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Device Type
2.4. Snippet by Indication
2.5. Snippet by End-User
2.6. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Global Incidence of Stroke and Neurovascular Disorders
3.1.1.2. Integration of Robotics, AI, and Real-Time Navigation Technologies
3.1.2. Restraints
3.1.2.1. Device-related Risks, Complications, and Safety Concerns
3.1.2.2. High Cost of Devices and Limited Reimbursement Coverage
3.1.3. Opportunity
3.1.3.1. Expanding Adoption in Emerging Economies with Growing Stroke Infrastructure
3.1.3.2. Biocompatible Materials and Device Coatings Improving Safety and Outcomes
3.1.4. Impact Analysis
4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established Leaders with the Largest Marketing Brand
4.1.3. Market Leaders with Established Products
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Forces Analysis
4.5. Patent Analysis
4.6. Unmet Needs and Gaps
4.7. Recommended Strategies for Market Entry and Expansion
4.8. Pricing Analysis and Price Dynamics
5. INTERVENTIONAL NEUROLOGY DEVICES MARKET, BY DEVICE TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
5.1.2. Market Attractiveness Index, By Device Type
5.2. Neurovascular Stents*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Embolic Coils
5.4. Aspiration Catheters
5.5. Microcatheters and Guidewires
5.6. Balloon Catheters
5.7. Others
6. INTERVENTIONAL NEUROLOGY DEVICES MARKET, BY INDICATION
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
6.1.2. Market Attractiveness Index, By Indication
6.2. Ischemic Stroke*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Hemorrhagic Stroke
6.4. Cerebral Aneurysm
6.5. Arteriovenous Malformation
6.6. Carotid/Extra-Cranial Stenosis
6.7. Others
7. INTERVENTIONAL NEUROLOGY DEVICES MARKET, BY END-USER
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.1.2. Market Attractiveness Index, By End-User
7.2. Hospitals*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Specialty Clinics
7.4. Ambulatory Surgical Centers
7.5. Others
8. INTERVENTIONAL NEUROLOGY DEVICES MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.2.6.1. U.S.
8.2.6.2. Canada
8.2.6.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.3.6.1. Germany
8.3.6.2. UK
8.3.6.3. France
8.3.6.4. Spain
8.3.6.5. Italy
8.3.6.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.4.6.1. China
8.4.6.2. India
8.4.6.3. Japan
8.4.6.4. South Korea
8.4.6.5. Rest of Asia-Pacific
8.5. South America
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.5.6.1. Brazil
8.5.6.2. Argentina
8.5.6.3. Rest of South America
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. Key Developments in Product Portfolios and Innovations
9.5. Company Benchmarking
10. COMPANY PROFILES
10.1. Medtronic*
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.2.1. Product Description
10.1.2.2. Product Key Performance Indicators (KPIs)
10.1.3. Financial Overview
10.1.3.1. Company Revenue
10.1.3.2. Geographical Revenue Shares
10.1.3.3. Revenue Forecasts
10.1.4. Key Developments
10.1.4.1. Mergers & Acquisitions
10.1.4.2. Key Product Development Activities
10.1.4.3. Regulatory Approvals, etc.
10.1.4.4. SWOT Analysis
10.2. Stryker
10.3. Johnson & Johnson
10.4. Penumbra, Inc.
10.5. Terumo Corporation
10.6. Boston Scientific Corporation
10.7. MicroPort Scientific Corporation
10.8. Acandis GmbH (LIST NOT EXHAUSTIVE)
11. ASSUMPTIONS AND RESEARCH METHODOLOGY
11.1. Data Collection Methods
11.2. Data Triangulation
11.3. Forecasting Techniques
11.4. Data Verification and Validation
12. APPENDIX
12.1. About Us and Services
12.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Device Type
2.4. Snippet by Indication
2.5. Snippet by End-User
2.6. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Global Incidence of Stroke and Neurovascular Disorders
3.1.1.2. Integration of Robotics, AI, and Real-Time Navigation Technologies
3.1.2. Restraints
3.1.2.1. Device-related Risks, Complications, and Safety Concerns
3.1.2.2. High Cost of Devices and Limited Reimbursement Coverage
3.1.3. Opportunity
3.1.3.1. Expanding Adoption in Emerging Economies with Growing Stroke Infrastructure
3.1.3.2. Biocompatible Materials and Device Coatings Improving Safety and Outcomes
3.1.4. Impact Analysis
4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established Leaders with the Largest Marketing Brand
4.1.3. Market Leaders with Established Products
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Forces Analysis
4.5. Patent Analysis
4.6. Unmet Needs and Gaps
4.7. Recommended Strategies for Market Entry and Expansion
4.8. Pricing Analysis and Price Dynamics
5. INTERVENTIONAL NEUROLOGY DEVICES MARKET, BY DEVICE TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
5.1.2. Market Attractiveness Index, By Device Type
5.2. Neurovascular Stents*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Embolic Coils
5.4. Aspiration Catheters
5.5. Microcatheters and Guidewires
5.6. Balloon Catheters
5.7. Others
6. INTERVENTIONAL NEUROLOGY DEVICES MARKET, BY INDICATION
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
6.1.2. Market Attractiveness Index, By Indication
6.2. Ischemic Stroke*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Hemorrhagic Stroke
6.4. Cerebral Aneurysm
6.5. Arteriovenous Malformation
6.6. Carotid/Extra-Cranial Stenosis
6.7. Others
7. INTERVENTIONAL NEUROLOGY DEVICES MARKET, BY END-USER
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.1.2. Market Attractiveness Index, By End-User
7.2. Hospitals*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Specialty Clinics
7.4. Ambulatory Surgical Centers
7.5. Others
8. INTERVENTIONAL NEUROLOGY DEVICES MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.2.6.1. U.S.
8.2.6.2. Canada
8.2.6.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.3.6.1. Germany
8.3.6.2. UK
8.3.6.3. France
8.3.6.4. Spain
8.3.6.5. Italy
8.3.6.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.4.6.1. China
8.4.6.2. India
8.4.6.3. Japan
8.4.6.4. South Korea
8.4.6.5. Rest of Asia-Pacific
8.5. South America
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.5.6.1. Brazil
8.5.6.2. Argentina
8.5.6.3. Rest of South America
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. Key Developments in Product Portfolios and Innovations
9.5. Company Benchmarking
10. COMPANY PROFILES
10.1. Medtronic*
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.2.1. Product Description
10.1.2.2. Product Key Performance Indicators (KPIs)
10.1.3. Financial Overview
10.1.3.1. Company Revenue
10.1.3.2. Geographical Revenue Shares
10.1.3.3. Revenue Forecasts
10.1.4. Key Developments
10.1.4.1. Mergers & Acquisitions
10.1.4.2. Key Product Development Activities
10.1.4.3. Regulatory Approvals, etc.
10.1.4.4. SWOT Analysis
10.2. Stryker
10.3. Johnson & Johnson
10.4. Penumbra, Inc.
10.5. Terumo Corporation
10.6. Boston Scientific Corporation
10.7. MicroPort Scientific Corporation
10.8. Acandis GmbH (LIST NOT EXHAUSTIVE)
11. ASSUMPTIONS AND RESEARCH METHODOLOGY
11.1. Data Collection Methods
11.2. Data Triangulation
11.3. Forecasting Techniques
11.4. Data Verification and Validation
12. APPENDIX
12.1. About Us and Services
12.2. Contact Us
LIST OF TABLES
Table 1 Global Interventional Neurology Devices Market Value, By Device Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Interventional Neurology Devices Market Value, By Indication, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Interventional Neurology Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Interventional Neurology Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Interventional Neurology Devices Market Value, By Device Type, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Interventional Neurology Devices Market Value, By Device Type, 2022-2033 (US$ Billion)
Table 7 Global Interventional Neurology Devices Market Value, By Indication, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global Interventional Neurology Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 9 Global Interventional Neurology Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global Interventional Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 11 Global Interventional Neurology Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global Interventional Neurology Devices Market Value, By Region, 2022-2033 (US$ Billion)
Table 13 North America Interventional Neurology Devices Market Value, By Device Type, 2022-2033 (US$ Billion)
Table 14 North America Interventional Neurology Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 15 North America Interventional Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 16 North America Interventional Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 17 Europe Interventional Neurology Devices Market Value, By Device Type, 2022-2033 (US$ Billion)
Table 18 Europe Interventional Neurology Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 19 Europe Interventional Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 20 Europe Interventional Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Asia-Pacific Interventional Neurology Devices Market Value, By Device Type, 2022-2033 (US$ Billion)
Table 22 Asia-Pacific Interventional Neurology Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 23 Asia-Pacific Interventional Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 24 Asia-Pacific Interventional Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 South America Interventional Neurology Devices Market Value, By Device Type, 2022-2033 (US$ Billion)
Table 26 South America Interventional Neurology Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 27 South America Interventional Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 28 South America Interventional Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 29 Middle East and Africa Interventional Neurology Devices Market Value, By Device Type, 2022-2033 (US$ Billion)
Table 30 Middle East and Africa Interventional Neurology Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 31 Middle East and Africa Interventional Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 32 Middle East and Africa Interventional Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 33 Medtronic: Overview
Table 34 Medtronic: Product Portfolio
Table 35 Medtronic: Key Developments
Table 36 Stryker: Overview
Table 37 Stryker: Product Portfolio
Table 38 Stryker: Key Developments
Table 39 Johnson & Johnson: Overview
Table 40 Johnson & Johnson: Product Portfolio
Table 41 Johnson & Johnson: Key Developments
Table 42 Penumbra, Inc.: Overview
Table 43 Penumbra, Inc.: Product Portfolio
Table 44 Penumbra, Inc.: Key Developments
Table 45 Terumo Corporation: Overview
Table 46 Terumo Corporation: Product Portfolio
Table 47 Terumo Corporation: Key Developments
Table 48 Boston Scientific Corporation: Overview
Table 49 Boston Scientific Corporation: Product Portfolio
Table 50 Boston Scientific Corporation: Key Developments
Table 51 MicroPort Scientific Corporation: Overview
Table 52 MicroPort Scientific Corporation: Product Portfolio
Table 53 MicroPort Scientific Corporation: Key Developments
Table 54 Acandis GmbH: Overview
Table 55 Acandis GmbH: Product Portfolio
Table 56 Acandis GmbH: Key Developments
Table 1 Global Interventional Neurology Devices Market Value, By Device Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Interventional Neurology Devices Market Value, By Indication, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Interventional Neurology Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Interventional Neurology Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Interventional Neurology Devices Market Value, By Device Type, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Interventional Neurology Devices Market Value, By Device Type, 2022-2033 (US$ Billion)
Table 7 Global Interventional Neurology Devices Market Value, By Indication, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global Interventional Neurology Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 9 Global Interventional Neurology Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global Interventional Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 11 Global Interventional Neurology Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global Interventional Neurology Devices Market Value, By Region, 2022-2033 (US$ Billion)
Table 13 North America Interventional Neurology Devices Market Value, By Device Type, 2022-2033 (US$ Billion)
Table 14 North America Interventional Neurology Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 15 North America Interventional Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 16 North America Interventional Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 17 Europe Interventional Neurology Devices Market Value, By Device Type, 2022-2033 (US$ Billion)
Table 18 Europe Interventional Neurology Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 19 Europe Interventional Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 20 Europe Interventional Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Asia-Pacific Interventional Neurology Devices Market Value, By Device Type, 2022-2033 (US$ Billion)
Table 22 Asia-Pacific Interventional Neurology Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 23 Asia-Pacific Interventional Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 24 Asia-Pacific Interventional Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 South America Interventional Neurology Devices Market Value, By Device Type, 2022-2033 (US$ Billion)
Table 26 South America Interventional Neurology Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 27 South America Interventional Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 28 South America Interventional Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 29 Middle East and Africa Interventional Neurology Devices Market Value, By Device Type, 2022-2033 (US$ Billion)
Table 30 Middle East and Africa Interventional Neurology Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 31 Middle East and Africa Interventional Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 32 Middle East and Africa Interventional Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 33 Medtronic: Overview
Table 34 Medtronic: Product Portfolio
Table 35 Medtronic: Key Developments
Table 36 Stryker: Overview
Table 37 Stryker: Product Portfolio
Table 38 Stryker: Key Developments
Table 39 Johnson & Johnson: Overview
Table 40 Johnson & Johnson: Product Portfolio
Table 41 Johnson & Johnson: Key Developments
Table 42 Penumbra, Inc.: Overview
Table 43 Penumbra, Inc.: Product Portfolio
Table 44 Penumbra, Inc.: Key Developments
Table 45 Terumo Corporation: Overview
Table 46 Terumo Corporation: Product Portfolio
Table 47 Terumo Corporation: Key Developments
Table 48 Boston Scientific Corporation: Overview
Table 49 Boston Scientific Corporation: Product Portfolio
Table 50 Boston Scientific Corporation: Key Developments
Table 51 MicroPort Scientific Corporation: Overview
Table 52 MicroPort Scientific Corporation: Product Portfolio
Table 53 MicroPort Scientific Corporation: Key Developments
Table 54 Acandis GmbH: Overview
Table 55 Acandis GmbH: Product Portfolio
Table 56 Acandis GmbH: Key Developments
LIST OF FIGURES
Figure 1 Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Interventional Neurology Devices Market Share, By Device Type, 2024 & 2033 (%)
Figure 3 Global Interventional Neurology Devices Market Share, By Indication, 2024 & 2033 (%)
Figure 4 Global Interventional Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 5 Global Interventional Neurology Devices Market Share, By Region, 2024 & 2033 (%)
Figure 6 Global Interventional Neurology Devices Market Y-o-Y Growth, By Device Type, 2023-2033 (%)
Figure 7 Neurovascular Stents Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 8 Embolic Coils Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 9 Aspiration Catheters Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 10 Microcatheters and Guidewires Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 11 Balloon Catheters Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 12 Others Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 13 Global Interventional Neurology Devices Market Y-o-Y Growth, By Indication, 2023-2033 (%)
Figure 14 Ischemic Stroke Indication in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 15 Hemorrhagic Stroke Indication in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 16 Cerebral Aneurysm Indication in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 17 Arteriovenous Malformation Indication in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 18 Carotid/Extra-Cranial Stenosis Indication in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 19 Others Indication in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 20 Global Interventional Neurology Devices Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 21 Hospitals End-User in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 22 Specialty Clinics End-User in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 23 Ambulatory Surgical Centers End-User in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 24 Others End-User in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 25 Global Interventional Neurology Devices Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 26 North America Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 27 North America Interventional Neurology Devices Market Share, By Device Type, 2024 & 2033 (%)
Figure 28 North America Interventional Neurology Devices Market Share, By Indication, 2024 & 2033 (%)
Figure 29 North America Interventional Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 30 North America Interventional Neurology Devices Market Share, By Country, 2024 & 2033 (%)
Figure 31 Europe Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 32 Europe Interventional Neurology Devices Market Share, By Device Type, 2024 & 2033 (%)
Figure 33 Europe Interventional Neurology Devices Market Share, By Indication, 2024 & 2033 (%)
Figure 34 Europe Interventional Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 35 Europe Interventional Neurology Devices Market Share, By Country, 2024 & 2033 (%)
Figure 36 Asia-Pacific Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 37 Asia-Pacific Interventional Neurology Devices Market Share, By Device Type, 2024 & 2033 (%)
Figure 38 Asia-Pacific Interventional Neurology Devices Market Share, By Indication, 2024 & 2033 (%)
Figure 39 Asia-Pacific Interventional Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 40 Asia-Pacific Interventional Neurology Devices Market Share, By Country, 2024 & 2033 (%)
Figure 41 South America Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 42 South America Interventional Neurology Devices Market Share, By Device Type, 2024 & 2033 (%)
Figure 43 South America Interventional Neurology Devices Market Share, By Indication, 2024 & 2033 (%)
Figure 44 South America Interventional Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 45 South America Interventional Neurology Devices Market Share, By Country, 2024 & 2033 (%)
Figure 46 Middle East and Africa Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 47 Middle East and Africa Interventional Neurology Devices Market Share, By Device Type, 2024 & 2033 (%)
Figure 48 Middle East and Africa Interventional Neurology Devices Market Share, By Indication, 2024 & 2033 (%)
Figure 49 Middle East and Africa Interventional Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 50 Medtronic: Financials
Figure 51 Stryker: Financials
Figure 52 Johnson & Johnson: Financials
Figure 53 Penumbra, Inc.: Financials
Figure 54 Terumo Corporation: Financials
Figure 55 Boston Scientific Corporation: Financials
Figure 56 MicroPort Scientific Corporation: Financials
Figure 57 Acandis GmbH: Financials
Figure 1 Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Interventional Neurology Devices Market Share, By Device Type, 2024 & 2033 (%)
Figure 3 Global Interventional Neurology Devices Market Share, By Indication, 2024 & 2033 (%)
Figure 4 Global Interventional Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 5 Global Interventional Neurology Devices Market Share, By Region, 2024 & 2033 (%)
Figure 6 Global Interventional Neurology Devices Market Y-o-Y Growth, By Device Type, 2023-2033 (%)
Figure 7 Neurovascular Stents Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 8 Embolic Coils Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 9 Aspiration Catheters Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 10 Microcatheters and Guidewires Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 11 Balloon Catheters Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 12 Others Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 13 Global Interventional Neurology Devices Market Y-o-Y Growth, By Indication, 2023-2033 (%)
Figure 14 Ischemic Stroke Indication in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 15 Hemorrhagic Stroke Indication in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 16 Cerebral Aneurysm Indication in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 17 Arteriovenous Malformation Indication in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 18 Carotid/Extra-Cranial Stenosis Indication in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 19 Others Indication in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 20 Global Interventional Neurology Devices Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 21 Hospitals End-User in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 22 Specialty Clinics End-User in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 23 Ambulatory Surgical Centers End-User in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 24 Others End-User in Global Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 25 Global Interventional Neurology Devices Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 26 North America Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 27 North America Interventional Neurology Devices Market Share, By Device Type, 2024 & 2033 (%)
Figure 28 North America Interventional Neurology Devices Market Share, By Indication, 2024 & 2033 (%)
Figure 29 North America Interventional Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 30 North America Interventional Neurology Devices Market Share, By Country, 2024 & 2033 (%)
Figure 31 Europe Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 32 Europe Interventional Neurology Devices Market Share, By Device Type, 2024 & 2033 (%)
Figure 33 Europe Interventional Neurology Devices Market Share, By Indication, 2024 & 2033 (%)
Figure 34 Europe Interventional Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 35 Europe Interventional Neurology Devices Market Share, By Country, 2024 & 2033 (%)
Figure 36 Asia-Pacific Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 37 Asia-Pacific Interventional Neurology Devices Market Share, By Device Type, 2024 & 2033 (%)
Figure 38 Asia-Pacific Interventional Neurology Devices Market Share, By Indication, 2024 & 2033 (%)
Figure 39 Asia-Pacific Interventional Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 40 Asia-Pacific Interventional Neurology Devices Market Share, By Country, 2024 & 2033 (%)
Figure 41 South America Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 42 South America Interventional Neurology Devices Market Share, By Device Type, 2024 & 2033 (%)
Figure 43 South America Interventional Neurology Devices Market Share, By Indication, 2024 & 2033 (%)
Figure 44 South America Interventional Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 45 South America Interventional Neurology Devices Market Share, By Country, 2024 & 2033 (%)
Figure 46 Middle East and Africa Interventional Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 47 Middle East and Africa Interventional Neurology Devices Market Share, By Device Type, 2024 & 2033 (%)
Figure 48 Middle East and Africa Interventional Neurology Devices Market Share, By Indication, 2024 & 2033 (%)
Figure 49 Middle East and Africa Interventional Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 50 Medtronic: Financials
Figure 51 Stryker: Financials
Figure 52 Johnson & Johnson: Financials
Figure 53 Penumbra, Inc.: Financials
Figure 54 Terumo Corporation: Financials
Figure 55 Boston Scientific Corporation: Financials
Figure 56 MicroPort Scientific Corporation: Financials
Figure 57 Acandis GmbH: Financials
